IFNG and breast cancer: To eliminate the potential pleiotropic effects of IFNγ pre-treatment in the trans-suppression co-culture assay, we used the human breast cancer cell line MDA-MB-231BR, which has a high PDL1 basal cell surface expression level (Figure S6A).